 |
You have requested:
Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myelomaPaul Richardson;
Constantine Mitsiades;
Kathleen Colson;
Eileen Reilly;
Laura McBride;
Judy Chiao;
Linda Sun;
Justin Ricker;
Syed Rizvi;
Carol Oerth;
Barbara Atkins;
Ivy Fearen;
Kenneth Anderson;
David Siegel
Leukemia and Lymphoma, 1029-2403, Volume 49, Issue 3, First published on 31 January 2008 Pages 502 – 507 View Abstract
In order to access this article you must be a subscriber or you need to purchase the article.
Please sign in to access your subscribed content, or select a purchase option.
|
Purchase
Single Article Purchase:
US$50.00
-
buy now 
add to cart 
[ show other buying options ]
|
purchase type
|
customer type |
online access |
payment method |
price |
|
Single Article Purchase
|
Any
|
3 days,
1 user,
3 cookies
|
credit card
|
US$50.00
|
buy now
add to cart
|
|
Issue Purchase
|
Any
|
permanent
|
credit card
|
US$384.16
|
buy now
add to cart
|
For a full range of prices please click here or call customer services on 02070 175540 (UK)
If you would like to pay in any other currency please see the purchasing help pages for more information.
If you are an agent wanting to subscribe on behalf of your customer please contact our subscriptions department on the following email address: subscriptions@tandf.co.uk
|
|
|
|
 |
|
|
